Therapeutic Effect of a New Immunosuppressant, FK-506, on Vasospasm after Subarachnoid Hemorrhage
- 1 June 1993
- journal article
- Published by Wolters Kluwer Health in Neurosurgery
- Vol. 32 (6) , 986-992
- https://doi.org/10.1227/00006123-199306000-00018
Abstract
WE HYPOTHESIZED THAT the immunological reaction against extravasated blood might play a role in the development of vasospasm after subarachnoid hemorrKeywords
This publication has 14 references indexed in Scilit:
- Evidence of the role of hemolysis in experimental cerebral vasospasmJournal of Neurosurgery, 1990
- The role of inflammation in experimental cerebral vasospasmJournal of Neurosurgery, 1990
- OPTIMAL SERUM TROUGH LEVELS OF FK506 IN RENAL ALLOTRANSPLANTATION OF THE BEAGLE DOGTransplantation, 1989
- The Immunosuppressant FK-506, like Cyclosporins and Didemnin B, Inhibits Calmodulin-Dependent Phosphorylation of the Elongation Factor 2 in vitro and BiolImmunobiology, 1989
- STUDIES OF THE EFFECTS OF FK506 ON RENAL ALLOGRAFTING IN THE BEAGLE DOGTransplantation, 1987
- Immune complexes and complement activation following rupture of intracranial saccular aneurysmsJournal of Neurosurgery, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro.The Journal of Antibiotics, 1987
- FK-506, a novel immunosuppressant isolated from a Streptomyces. I. Fermentation, isolation, and physico-chemical and biological characteristics.The Journal of Antibiotics, 1987
- Response of chronic experimental cerebral vasospasm to methylprednisolone and dexamethasoneJournal of Neurosurgery, 1984
- Prevention of chronic experimental cerebral vasospasm with ibuprofen and high-dose methylprednisoloneJournal of Neurosurgery, 1983